ENTX
Entera Bio (ENTX)
$87
About Entera Bio (ENTX)
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Details
Daily high
$2.97
Daily low
$2.80
Price at open
$2.80
52 Week High
$4.20
52 Week Low
$0.91
Market cap
139.0M
Dividend yield
0.00%
Volume
244,946
Avg. volume
4.9M
P/E ratio
-10.71
Entera Bio News
Details
Daily high
$2.97
Daily low
$2.80
Price at open
$2.80
52 Week High
$4.20
52 Week Low
$0.91
Market cap
139.0M
Dividend yield
0.00%
Volume
244,946
Avg. volume
4.9M
P/E ratio
-10.71